Why is Chemo Pharma Lab falling/rising?

As of 29-Sep, Chemo Pharma Laboratories Ltd is experiencing a price increase, currently at Rs 121.90, which reflects a rise of Rs 7.9 or 6.93%. The stock opened with a significant gain of 8.25% today and reached an intraday high of Rs 123.4. It has outperformed its sector by 7.71% today, and the delivery volume has increased by 50.95% compared to the 5-day average, indicating rising investor participation. Over the past year, the stock has shown impressive returns, with a 76.64% increase, while its year-to-date return stands at 10.98%. However, the positive and negative factors dashboard is unavailable, which limits further insights into specific catalysts for this movement.
Broader Market Context: In the context of the broader market, Chemo Pharma's short-term performance has been notably strong, with a 1-week return of +0.91%, contrasting with the Sensex's decline of -2.18% over the same period. This divergence highlights the stock's resilience and attractiveness to investors, especially given its substantial long-term returns of 248.29% over three years and 527.38% over five years, compared to the Sensex's more modest gains. Overall, the stock's strong performance relative to the benchmark suggests a favorable sentiment among investors despite broader market challenges.